| 000 | 01832 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513045755.0 | ||
| 264 | 0 | _c19950323 | |
| 008 | 199503s 0 0 eng d | ||
| 022 | _a0941-4355 | ||
| 024 | 7 |
_a10.1007/BF00344055 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSorbe, B | |
| 245 | 0 | 0 |
_aTropisetron (Navoban) in the prevention of chemotherapy-induced nausea and vomiting--the Nordic experience. _h[electronic resource] |
| 260 |
_bSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer _cNov 1994 |
||
| 300 |
_a393-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntiemetics _xadverse effects |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFinland |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNausea _xchemically induced |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aScandinavian and Nordic Countries |
| 650 | 0 | 4 | _aSex Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aTropisetron |
| 650 | 0 | 4 |
_aVomiting _xchemically induced |
| 700 | 1 | _aAndersson, H | |
| 700 | 1 | _aSchmidt, M | |
| 700 | 1 | _aSöderberg, M | |
| 700 | 1 | _aHögberg, T | |
| 700 | 1 | _aWernstedt, L | |
| 700 | 1 | _aJanson, E T | |
| 700 | 1 | _aEhrnström, B | |
| 700 | 1 | _aKjaer, M | |
| 700 | 1 | _aHavsteen, H | |
| 773 | 0 |
_tSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer _gvol. 2 _gno. 6 _gp. 393-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00344055 _zAvailable from publisher's website |
| 999 |
_c7858270 _d7858270 |
||